Observational studyBMJ open2026

Use of SGLT2 inhibitors and GLP-1 receptor agonists in patients with ischaemic heart disease and type 2 diabetes in Swedish primary care: a cross-sectional analysis of regional primary care registry data (QregPV).

Tobias Andersson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.